Methods of estimating prevalence of multiple sclerosis in six European healthcare data sources: a contribution from the ConcePTION project
Marie Beslay(Université Toulouse III - Paul Sabatier), Joan K. Morris(St George's, University of London), Aurora Puccini(University of Bologna), Laia Barrachina‐Bonet(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Clara Cavero‐Carbonell(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Sandra López‐León(Rutgers, The State University of New Jersey), Kerstin Hellwig(St. Josef-Hospital), Marco Manfrini(University of Padua), Vera Ruth Mitter(Bern University of Applied Sciences), Yvonne Geissbühler(Novartis (Switzerland)), Anja Geldhof, Justine Bénevent(Université Toulouse III - Paul Sabatier), Davide Messina(Regional Health), Maarit K. Leinonen(University of Helsinki), Rosa Gini(Agenzia Regionale di Sanità della Toscana), Sue Jordan(Swansea University), Elisa Ballardini(University of Ferrara), Visa Martikainen(Finnish Institute for Health and Welfare), Christine Damase‐Michel(Inserm), Amanda J. Neville(University of Ferrara), Sandra Vukusic(Université Claude Bernard Lyon 1), Hedvig Nordeng(University of Oslo), Anna‐Belle Beau(Inserm), Alex Coldea(Swansea University), Laura García‐Villodre(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana)
Cited by 0
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
|New England Journal of Medicine|2013|1k
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
|The American Journal of Medicine|2009|941
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510